CLINICAL PHARMACOKINETICS OF BEZAFIBRATE IN PATIENTS WITH IMPAIRED RENAL-FUNCTION

被引：22

作者：

ANDERSON, P

NORBECK, HE

机构：

[1] KAROLINSKA HOSP,DEPT INTERNAL MED,S-10401 STOCKHOLM,SWEDEN

[2] KAROLINSKA HOSP,KING GUSTAF V RES INST,S-10401 STOCKHOLM,SWEDEN

来源：

关键词：

D O I：

10.1007/BF00627922

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：209 / 214

页数：6

共 14 条

[1] DISPOSITION PHARMACOKINETICS OF BEZAFIBRATE IN MAN
ABSHAGEN, U
BABLOK, W
KOCH, K
LANG, PD
SCHMIDT, HAE
SENN, M
STORK, H
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (01) : 31 - 38
[2] STEADY-STATE KINETICS OF BEZAFIBRATE AND CLOFIBRATE IN HEALTHY FEMALE VOLUNTEERS
ABSHAGEN, U
SPORLRADUN, S
MARINOW, J
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (04) : 305 - 308
[3] PHARMACOKINETICS OF BEZAFIBRATE AFTER SINGLE AND MULTIPLE DOSES IN THE PRESENCE OF RENAL-FAILURE
ABSHAGEN, U
KOSTERS, W
KAUFMANN, B
LANG, PD
[J]. KLINISCHE WOCHENSCHRIFT, 1980, 58 (17): : 889 - 896
[4] ARNTZ HR, 1978, MED KLIN, V73, P1731
[5] Bolzano K, 1979, Acta Med Austriaca, V6, P90
[6] GAS-CHROMATOGRAPHIC METHOD FOR DETERMINATION OF BEZAFIBRATE IN SERUM AND URINE
ENDELE, R
[J]. JOURNAL OF CHROMATOGRAPHY, 1978, 154 (02): : 261 - 263
[7] GOLDBERG AP, 1977, CLIN PHARMACOL THER, V21, P317
[8] KATSILAMBROS N, 1972, NEW ENGL J MED, V286, P1110
[9] KOSTER W, 1979, LIPOPROTEINE HERZINF, P113
[10] LAGEDER H, 1978, INT C ATHEROSCLEROSI, P726